Fahotyp and sensitivity to medications phage film-forming strains Staphylococcus aureus, isolated from respiratory tract

• Autorzy: Voronkova O.S. , Vinnikov A.I.
• Języki publikacji: EN

Abstrakty

EN

The study of biological properties of filmforming Staphylococcus aureus strains, including its sensitivity to bacteriophages, is one of the important tasks of laboratory diagnostic service that allows, if it necessary, choose an alternative treatment strategy and to establish the sources of strains. In the study of material from the nose and throat of 26 persons-volunteers the strains of S. aureus were selected. Among them 16 (61.5%) were able to form biofilms. Analysis of resistance to phages drugs of filmformation strains of S. aureus showed that 87.5% strains were sensitive the phages drugs "Piobacteriophage" and "Bacteriophage staphylococcal liquid". Phage type was identified for 9 (56.3%) strains. 64.3% of these strains were sensitive to the 1 phage from set, 21.4% – to 2 and 14.3% – 3 phages. It was determined that 77.8% strains were typed by phages from third group. For 1 strain detected simultaneous sensitivity to phages of 2 and 3 groups. With phage 81 (out of group phage) interacted 4 strains: 2 showed sensitivity only to him and another 2 were also susceptible to phage of third group.

Słowa kluczowe

EN

Staphylococcus; Staphylococcus aureus; bacterial strain; biofilm formation; microbiota; phage; phage typing; bacteriophage; respiratory tract; drug sensitivity

• Wydawca: -
• Czasopismo: International Letters of Natural Sciences
• Rocznik: 2016
• Tom: 51
• Opis fizyczny: p.1-5,fig.,ref.

Twórcy

autor

Voronkova O.S.

• Oles Honchar Dnipropetrovsk National University, Gagarin av., 72, Dnipropetrovsk, Ukraine

autor

Vinnikov A.I.

• Oles Honchar Dnipropetrovsk National University, Gagarin av., 72, Dnipropetrovsk, Ukraine

Bibliografia

• [1] Т.D. Savchuk, Staphylococcal infections, Medicine, Moscow, 2003.
• [2] J. Klem, D. Dömötör, G.Schneider, T. Kovács, A. Tóth, G. Rákhely, Bacteriophage therapy against Staphylococci, Acta Microbiol. Immunol. Hungarica. 60(4) (2013) 411–422.
• [3] A.K. Seth, M.R. Geringer, K.T. Nguyen, S.P. Agnew, Z. Dumanian, R.D. Galiano, K.P. Leung, T.A. Mustoe, S.J.Hong, Bacteriophage therapy for staphylococcus aureus biofilm-infected wounds: a new approach to chronic wound care, Plast. Reconstr. Surg. 131(2) (2013) 225–234.
• [4] N.K. Archer, M.J. Mazaitis, W. Costerton, J.G. Leid, M.E. Powers, M.E. Shirtliff, Staphylococcus aureus biofilms: properties, regulation and roles in human disease, Virulence. 2(5) (2011) 445–459.
• [5] B.K. Chan, S.T. Abedon, C. Loc-Carrillo, Phage cocktails and the future of phage therapy, Future Microbiol. 8(6) (2013) 769–783.
• [6] C. Potera, Phage renaissance: new hope against antibiotic resistance, Envir. Health Perspect. 121(2) (2013) a48–a53.
• [7] A. Sulakvelidze, Z. Alavidze, G. Morris jr., Bacteriophage therapy, Antimicrob. Agents Chemother. 45(3) (2001) 649–659.
• [8] J. Ziemska, A. Rajnisz, J. Solecka, New perspectives on antibacterial drug research, Cent. Eur. J. Biol. 8(10) (2013) 943-957.
• [9] R. Pantucek, J. Doskar, V. Ruzickova, P. Kasparek, E. Oracova, V. Kvardova, S. Rosypal, Identification of bacteriophage types and their carriage in Staphylococcus aureus, Arch. Virol. 149 (2004) 1689–1703.
• [10] J.G. Holt, N.R. Кrieg, P.H.A. Sneath, J.T. Staley, S.T. Williams (Eds.), Bergey’s manual of determinative bacteriology, Williams & Wilkins, Baltimore, 1994.
• [11] I.I. Volkov, Improving the microbiological diagnosis of staphylococcal infections and environmental aspects of their pathogens, 1999. Information on http://nature.web.ru/db/msg.html?mid=1163020.
• [12] About the unification of microbiological (bacteriological) research methods used in clinical diagnostic laboratories of medical institutions: the order № 535, MOZ USSR, Moscow, 1985.
• [13] M.K. Roberts, The diagnosis of staphylococcal infection, Mir, Moscow, 2005.
• [14] S.H. Dzahurov, F.F. Rezepov (Eds.), Handbook of bacterial and viral preparations application, Medicine, Moscow, 1995.
• [15] D.H. Lloyd, Alternatives to conventional antimicrobial drugs: a review of future prospects, Vet. Dermatol. 23(4) (2012) 299–304.
• [16] Z. Hosseinidoust, N. Tufenkji, T.G.M. van de Ven, Formation of biofilms under phage predation: consid erations concerning a biofilm increase, Biofouling. 29(4) (2013) 457–468.
• [17] D.Z. Ekmuzheva, S.B. Khadzegova, Characteristic of the normal vaginal microflora in healthy women of reproductive age, Uspekhi sovremennogo estestvoznaniya. 6 (2003) 50–51.
• [18] O.E. Falova, N.I. Potaturkina-Nesterova, E.N. Ilina, Interrelation of intraspecific variety and genetic determinants of skin’s staphylococcus pathogenicity, Fundamental research. 12 (2013) 131–134.
• DOI References
• [2] J. Klem, D. Dömötör, G. Schneider, T. Kovács, A. Tóth, G. Rákhely, Bacteriophage therapy against Staphylococci, Acta Microbiol. Immunol. Hungarica. 60(4) (2013) 411-422. 10.1556/amicr.60.2013.4.3
• [3] A.K. Seth, M.R. Geringer, K.T. Nguyen, S.P. Agnew, Z. Dumanian, R.D. Galiano, K.P. Leung, T.A. Mustoe, S.J. Hong, Bacteriophage therapy for staphylococcus aureus biofilm-infected wounds: a new approach to chronic wound care, Plast. Reconstr. Surg. 131(2) (2013). 10.1097/prs.0b013e31827e47cd
• [4] N.K. Archer, M.J. Mazaitis, W. Costerton, J.G. Leid, M.E. Powers, M.E. Shirtliff, Staphylococcus aureus biofilms: properties, regulation and roles in human disease, Virulence. 2(5) (2011) 445-459. 10.4161/viru.2.5.17724
• [5] B.K. Chan, S.T. Abedon, C. Loc-Carrillo, Phage cocktails and the future of phage therapy, Future Microbiol. 8(6) (2013) 769-783. 10.2217/fmb.13.47
• [6] C. Potera, Phage renaissance: new hope against antibiotic resistance, Envir. Health Perspect. 121(2) (2013) a48-a53. 10.1289/ehp.121-a48
• [7] A. Sulakvelidze, Z. Alavidze, G. Morris jr., Bacteriophage therapy, Antimicrob. Agents Chemother. 45(3) (2001) 649-659. 10.1128/aac.45.3.649-659.2001
• [8] J. Ziemska, A. Rajnisz, J. Solecka, New perspectives on antibacterial drug research, Cent. Eur. J. Biol. 8(10) (2013) 943-957. 10.2478/s11535-013-0209-6
• [9] R. Pantucek, J. Doskar, V. Ruzickova, P. Kasparek, E. Oracova, V. Kvardova, S. Rosypal, Identification of bacteriophage types and their carriage in Staphylococcus aureus, Arch. Virol. 149 (2004) 1689-1703. 10.1007/s00705-004-0335-6
• [15] D.H. Lloyd, Alternatives to conventional antimicrobial drugs: a review of future prospects, Vet. Dermatol. 23(4) (2012) 299-304. 10.1111/j.1365-3164.2012.01042.x
• [16] Z. Hosseinidoust, N. Tufenkji, T.G.M. van de Ven, Formation of biofilms under phage predation: consid erations concerning a biofilm increase, Biofouling. 29(4) (2013) 457-468. 10.1080/08927014.2013.779370

Identyfikatory

DOI

10.18052/www.scipress.com/ILNS.51.1